2021 Webinars for Patients and Families

Women with HCL Webinar Series: Diet and Nutrition

November 18, 2021

Speaker: Lindsey Wohlford, Employee Wellness Dietitian at The University of Texas MD Anderson Cancer Center.

View materials from this webinar. >>

2021 Hairy Cell Leukemia Patient Seminar (Remote)

October 10-12, 2021

View materials from the patient seminar. >>

Webinar Series: What's New in HCL? Vemurafenib plus Rituximab in Relapsed or Refractory HCL

August 11, 2021

Speaker: Dr. Enrico Tiacci, Department of Medicine and Surgery, University of Perugia, Italy

View materials from this webinar. >>

Webinar for Women: HCL and Mental Health

May 26, 2021

Speaker: Karen Hartman, Department of Social Work, Memorial Sloan Kettering

View a summary of this webinar. >>

General HCL Webinar Series: Understanding HCL and Variants of HCL

May 3, 2021

Speaker: Dr. Robert J. Kreitman, National Cancer Institute, National Institutes of Health (NIH)
Dr. Kreitman provided an overview of HCL, a discussion of treatment protocols and a review of current clinical trials.

View materials from this webinar. >>

Webinar Series: What's New in HCL? Ibrutinib in Classic and Variant HCL

April 20, 2021

Speaker: Dr. Kerry Rogers, The Ohio State University

We are excited to launch a new webinar series that will explore the latest news and publications in HCL research. Through this series, investigators with recently published research will highlight their findings. Unlike our general HCL webinars that provide an overview of HCL and its therapies, each webinar in this new series will do a deeper dive into a single study or publication. On April 20th, Dr. Rogers presented results of a multisite phase 2 study of ibrutinib in patients with classic or variant hairy cell leukemia. These results were published in March 2021 in Blood, a journal of the American Society of Hematology (ASH). In 2017, Dr. Rogers was a member of the HCLF/SASS inaugural class of Fellowship Awardees. The fellowship grant award that year supported her research in Ibrutinib.

View materials from this webinar. >>

Webinar: COVID-19 and Hairy Cell Leukemia

February 11, 2021

Speakers:

  • Dr. Michael Grever from The Ohio State University in Columbus, Ohio

  • Dr. Bernhard Wörmann from Charité University Hospital in Berlin, Germany

View materials from this webinar. >>